Status:
UNKNOWN
Iron Metabolism in Small Pre Term Newborns
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Preterm
Iron Metabolism
Eligibility:
All Genders
Up to 6 years
Phase:
NA
Brief Summary
Iron is an essential micronutrient that plays an important role in cellular functions of all microorganisms. Both iron deficiency and iron excess during the early weeks of life can have severe effects...
Detailed Description
Primary objectives 1. The aim of the study is to investigate the presence and level of Cryptic LPI in pre term infants plasma before and during enteral iron supplementation. 2. To assess the iron sta...
Eligibility Criteria
Inclusion
- Very Low Birth Weight and / or borne at 30 weeks or less of gestational age that are scheduled to receive enteral iron supplementation as part of the standard protocol currently used by the Neonatal Intensive Care Unit.
- Birth weight will be not an inclusion or exclusion criteria for preterms born at 30 weeks or less.
Exclusion
- Major physical anomalies,
- renal or cardiac diseases,
- newborns that underwent major surgery during the study period,
- acute or chronic fetal blood loss,
- hemolytic anemia,
- refusal to receive parental consent.
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01443195
Start Date
October 1 2011
End Date
December 31 2020
Last Update
November 1 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, Israel, 18101